UK BMT Pharmacists’ Group – Educational Meeting 28th Feb 2025

The UK BMT Pharmacists’ Group (a special-interest group affiliated to BOPA) is running an educational meeting via Zoom on the afternoon of Friday 28th February 2025. The meeting will run from 2-4.30pm. There is no registration fee and no need to pre-register. The meeting agenda and all the details you need to log in can be found below. There is a single zoom link for this but please join any session as able.

Certificates of attendance will be issues upon completion of the evaluation form after the meeting.

The meeting agenda and all the details you need to log in can be found here: https://www.bopa.org.uk/bmtmeeting/

UK BMT Pharmacists Group Educational Meeting Agenda Feb 25

We look forward so seeing you there

Sinéad and Ritti

on behalf of the UK BMT Pharmacist Group Committee

 

 

 

 

 

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article